Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining Vaccine Effectiveness (VE) of Flublok Relative to Standard Dose Inactivated Influenza Vaccine Among Kaiser Permanente Northern California Members Aged 18-64 Years

NCT03694392 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03694392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03694392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining Vaccine Effectiveness (VE) of Flublok Relative to Standard Dose Inactivated Influenza Vaccine Among Kaiser Permanente Northern California Members Aged 18-64 Years
Lead sponsor
Kaiser Permanente
Phase
Observational
Overall status
Completed
Start date
September 16, 2018
Completion date
December 31, 2022
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, congestive heart failure, influenza, lower respiratory tract infection, pneumonia, stroke